FDA Expands CorPath Robotic System Labeling To Radial PCIs
This article was originally published in The Gray Sheet
Executive Summary
The company says as radial percutaneous coronary interventions continue to grow, FDA's 510(k) clearance gives more radiologists and interventional cardiologists access to a system that reduces their exposure to radiation.